Clinical Trial: A Study of LY4268989 (MORF 057) in Healthy Participants

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07707375) titled 'A Study of LY4268989 (MORF 057) in Healthy Participants' on July 13.

Brief Summary: The purpose of this study is to identify if two different tablets of LY4268989 (MORF 057) work similarly in healthy participants given different meals.

Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

There will be 18 inpatient stays at the clinical research unit (CRU). The study will last about 9 weeks.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: LY4268989

Administered orally

Recruitment Status: NOT_YET_RECRUITING ...